title: Biochemical analysis of metastasis-related Ax actin in B16 mouse melanoma cells after chemical reversional modulation and of tumor progression-related A' actin in the ontogeny of human malignant melanoma.
abstract: To examine the correlation between tumor metastasis and Ax actin in mouse melanoma and between tumor progression and A'.actin in human melanoma and further to investigate whether or not it is a generally existing principle, we studied the effects of reversion agents, which distinctly decrease metastatic ability of melanoma cells, on the appearance of Ax actin. Will an induced decrease in metastasis of established highly metastatic B16-F10 mouse melanoma cells cause the appearance of Ax actin? We also examined the appearance of A' actin in eight human benign pigment cell tumors and nine human malignant melanoma tissues or cells in relation to tumor progression. In vitro treatment of B16-F10 cells with each of these agents suppressed metastatic ability of the cells injected intravenously into syngenic mice; however, none of the treated cells represented Ax actin in vitro. These results suggest that the appearance of Ax actin may be a result of long-term tumor cell progression leading to changes in gene level, but because the treatments with these agents were only carried out over a short period, they could not effect changes in gene level; thus, Ax actin appearance remained unchanged. Appearance of A' actin was detected only in human benign pigment cell tumors such as nevus cell nevi, but not in malignant melanomas, which were also formed in a long period of tumor progression in vivo. These results suggest that A' actin is a clinically useful marker to determine the prognosis and level of tumor progression of human pigment cell tumors.
authors.affiliation: Department of Dermatology, Kobe University School of Medicine, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Sasase
authors.forename: Y
authors.initials: Y
authors.lastname: Mishima
authors.forename: M
authors.initials: M
authors.lastname: Ichihashi
authors.forename: S
authors.initials: S
authors.lastname: Taniguchi
mesh_terms: D000199:Actins / Q000032:analysis*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D005260:Female; D006801:Humans; D008545:Melanoma / Q000032:analysis / Q000201:enzymology / Q000473:pathology*; D008546:Melanoma, Experimental / Q000032:analysis / Q000201:enzymology / Q000473:pathology*; D051379:Mice; D008815:Mice, Inbred Strains; D014442:Monophenol Monooxygenase / Q000378:metabolism; D009362:Neoplasm Metastasis / Q000473:pathology*; D009506:Nevus / Q000032:analysis / Q000201:enzymology / Q000473:pathology*; D010641:Phenotype; D014407:Tumor Cells, Cultured / Q000032:analysis / Q000201:enzymology / Q000473:pathology
chemical_list: D000199:Actins; D000970:Antineoplastic Agents; D014442:Monophenol Monooxygenase